Stay updated on Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Sign up to get notified when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.4 to v3.5.5, indicating a new version of the page has been published. This revision update is a backend/version control detail rather than a substantive content change.
    Difference
    0.1%
    Check dated 2026-06-05T13:23:38.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows a new revision label Revision: v3.5.4, replacing the prior Revision: v3.5.3. This indicates a minor update to the page's metadata or presentation.
    Difference
    0.1%
    Check dated 2026-05-15T05:50:14.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page’s revision/version footer was updated from **v3.5.2** to **v3.5.3**, reflecting a site build or documentation update rather than a change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T06:10:56.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:44:08.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.5.0 released, replacing v3.4.3. This update updates the site version and UI without altering study details.
    Difference
    0.1%
    Check dated 2026-03-19T06:19:45.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is displayed, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:24:06.000Z thumbnail image

Stay in the know with updates to Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.